0.1674
price up icon15.93%   0.023
after-market Dopo l'orario di chiusura: .17 0.0026 +1.55%
loading

Adaptimmune Therapeutics Plc Adr Borsa (ADAP) Ultime notizie

pulisher
Sep 19, 2025

Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC - Yahoo Finance

Sep 19, 2025
pulisher
Sep 18, 2025

Must-Watch Streaming Stocks Poised to Gain From Content Boom - Yahoo Finance

Sep 18, 2025
pulisher
Sep 18, 2025

Is Hesai Group Sponsored ADR (HSAI) Outperforming Other Auto-Tires-Trucks Stocks This Year? - Yahoo Finance

Sep 18, 2025
pulisher
Sep 18, 2025

Lenovo Finds 65% of IT Leaders Admit Their Defenses Can’t Withstand AI Cybercrime - Yahoo Finance

Sep 18, 2025
pulisher
Sep 17, 2025

Why the Market Dipped But Li Auto Inc. Sponsored ADR (LI) Gained Today - Yahoo Finance

Sep 17, 2025
pulisher
Sep 14, 2025

What Does Wall Street Think About Li Auto Inc. (LI)? - Yahoo Finance

Sep 14, 2025
pulisher
Sep 12, 2025

Vestas Wind Systems AS ADR (VWDRY) Wind Turbines Orders on the Rise - Yahoo Finance

Sep 12, 2025
pulisher
Sep 11, 2025

The Zacks Analyst Blog Highlights Walmart, Alibaba, Shell, Omega Flex and Weyco - Yahoo Finance

Sep 11, 2025
pulisher
Sep 10, 2025

Investors Take Advantage Of 15.76% Gain In Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) - stocksregister.com

Sep 10, 2025
pulisher
Sep 10, 2025

What Is Going On With Top KingWin Ltd (NASDAQ: WAI)? - stocksregister.com

Sep 10, 2025
pulisher
Sep 06, 2025

Rio Tinto plc ADR Common Stock (RIO) Restructures to Focus on Profitable Assets - Yahoo Finance

Sep 06, 2025
pulisher
Sep 05, 2025

Zacks.com featured highlights include Halozyme Therapeutics, Phibro, Leidos and PDD Holdings - Yahoo Finance

Sep 05, 2025
pulisher
Sep 03, 2025

Adaptimmune Therapeutics CFO Wood sells $950 in shares - Investing.com

Sep 03, 2025
pulisher
Aug 29, 2025

Nio Inc. ADR (NIO) Upgraded to ‘Overweight’ at JPMorgan on Strong Vehicle Demand - Yahoo Finance

Aug 29, 2025
pulisher
Aug 21, 2025

Earnings call transcript: Adaptimmune Q2 2025 shows revenue beat, stock dips - Investing.com

Aug 21, 2025
pulisher
Aug 20, 2025

Questex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing - GlobeNewswire Inc.

Aug 20, 2025
pulisher
Aug 19, 2025

Adaptimmune director Behbahani sells shares worth $229,171 - Investing.com

Aug 19, 2025
pulisher
Aug 18, 2025

Are Investors Undervaluing ENGIESponsored ADR (ENGIY) Right Now? - Yahoo Finance

Aug 18, 2025
pulisher
Aug 14, 2025

Adaptimmune Faces Nasdaq Delisting Notice Amid Compliance Issues - MSN

Aug 14, 2025
pulisher
Aug 12, 2025

Is Piedmont Lithium Inc.Sponsored ADR (PLL) Stock Outpacing Its Basic Materials Peers This Year? - Yahoo Finance

Aug 12, 2025
pulisher
Aug 11, 2025

ADAP’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Aug 11, 2025
pulisher
Aug 06, 2025

HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View - Yahoo Finance

Aug 06, 2025
pulisher
Aug 05, 2025

Wall Street Today: Dow, Nasdaq, S&P 500 open higher as investors focus on optimism over potential US Fed rate cut - Mint

Aug 05, 2025
pulisher
Aug 04, 2025

Adaptimmune Therapeutics Plc ADR (ADAP) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Aug 04, 2025
pulisher
Jul 31, 2025

Best Momentum Stocks to Buy for July 31st - Yahoo Finance

Jul 31, 2025
pulisher
Jul 30, 2025

Ecor1 capital sells Adaptimmune Therapeutics (ADAP) shares for $6.89m By Investing.com - Investing.com India

Jul 30, 2025
pulisher
Jul 30, 2025

Ecor1 capital sells Adaptimmune Therapeutics (ADAP) shares for $6.89m - Investing.com

Jul 30, 2025
pulisher
Jul 29, 2025

Adaptimmune stock rating downgraded by H.C. Wainwright after asset sale - Investing.com South Africa

Jul 29, 2025
pulisher
Jul 28, 2025

Adaptimmune Therapeutics stock plunges after selling cell therapy assets By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

Adaptimmune Therapeutics stock plunges after selling cell therapy assets - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Adaptimmune sells cell therapy assets to US WorldMeds for $55 million - Investing.com

Jul 28, 2025
pulisher
Jul 24, 2025

XPeng Inc. Sponsored ADR (XPEV) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance

Jul 24, 2025
pulisher
Jul 21, 2025

Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect - Yahoo Finance

Jul 21, 2025
pulisher
Jun 25, 2025

Mizuho downgrades Adaptimmune stock on solvency concerns - Investing.com

Jun 25, 2025
pulisher
Jun 17, 2025

Financial Metrics Unveiled: MARA Holdings Inc (MARA)’s Key Ratios in the Spotlight - DWinneX

Jun 17, 2025
pulisher
Jun 12, 2025

Best Momentum Stocks to Buy for June 12th - Yahoo Finance

Jun 12, 2025
pulisher
May 30, 2025

Context Therapeutics names new CMO to advance T cell therapies By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 29, 2025

Context Therapeutics names new CMO to advance T cell therapies - Investing.com

May 29, 2025
pulisher
May 22, 2025

KANZHUN LIMITED Sponsored ADR (BZ) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

May 22, 2025
pulisher
May 13, 2025

Adaptimmune Therapeutics earnings beat by $0.09, revenue fell short of estimates - Investing.com UK

May 13, 2025
pulisher
May 13, 2025

Healthy Upside Potential: Merus N.V (MRUS) - Sete News

May 13, 2025
pulisher
May 12, 2025

How should investors view Jianzhi Education Technology Group Co Ltd ADR (JZ)? - uspostnews.com

May 12, 2025
pulisher
May 07, 2025

CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105 - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

All Markets & Instruments Available to Trade - Capital.com

May 06, 2025
pulisher
May 03, 2025

Adaptimmune Therapeutics Plc ADR’s (ADAP) Stock Is Harder To Predict Than You Think - Stocksregister

May 03, 2025
pulisher
May 01, 2025

Take off with Adaptimmune Therapeutics Plc ADR (ADAP): Get ready for trading - Sete News

May 01, 2025
pulisher
Apr 30, 2025

ADAP (Adaptimmune Therapeutics Plc ADR) may reap gains as insiders became active recently - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

AUTL’s Market Whiplash: -44.26% YTD Decline, -21.08% Plunge in 30 Days - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Adaptimmune Therapeutics Plc ADR (ADAP) Stock: Navigating Drops and Gains - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

ADAP underperforms with a -5.05 decrease in share price - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Closing Figures: Myriad Genetics, Inc (MYGN)’s Negative Finish at 7.20, Down -4.00 - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Stock Performance Spotlight: Adaptimmune Therapeutics Plc ADR (ADAP) Ends the Day at 0.26, Down by -5.05 - DWinneX

Apr 30, 2025
pulisher
Apr 28, 2025

Let’s Jump Into The Geron Corp (NASDAQ: GERN) Stock Forecast - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 26, 2025

Bausch + Lomb Corp (NYSE:BLCO)’s 12-Month Price Target Is Now Set At 23. - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 26, 2025

B. Riley Financial Inc (NASDAQ:RILY) Shares Dropped -2.22% In A Week. Can It Continue Rising? - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 26, 2025

Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) Could Really Rise To 4 In 12 Months, According To Analysts. - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 26, 2025

Is Live Oak Bancshares Inc (NYSE:LOB) A Better Buy Than Others After A -32.27% Fall In This Year? - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 26, 2025

Eventbrite Inc (NYSE:EB) Declines -81.18% In 2025; Are Investors Attracted By Its $2.10 Price? - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 24, 2025

The Adaptimmune Therapeutics Plc ADR (ADAP) had a good session last reading, didn’t it? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

How should investors view Lazard Inc (LAZ)? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Olema Pharmaceuticals Inc (OLMA)’s results reveal risk - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

It would be worthwhile to take a closer look at Quantum Corp (QMCO) - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Was there any good news for Neuronetics Inc (STIM) stock in the last session? - uspostnews.com

Apr 24, 2025
pulisher
Apr 22, 2025

Grammy Award Winning Artist Knows How Math Can Help Prevent Cancer - Yahoo Finance

Apr 22, 2025
pulisher
Apr 16, 2025

TransCode Therapeutics Inc: Weathering Stock Market Storms with 8.59M Market Cap - investchronicle.com

Apr 16, 2025
pulisher
Apr 03, 2025

Charting the Course: Tempest Therapeutics Inc’s TPST Stock Prospects - investchronicle.com

Apr 03, 2025
pulisher
Apr 02, 2025

Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) Today’s Hot Stock - stocksregister.com

Apr 02, 2025
pulisher
Apr 01, 2025

H.C. Wainwright cuts Adaptimmune stock target to $3, maintains Buy By Investing.com - Investing.com South Africa

Apr 01, 2025
$35.86
price down icon 1.05%
$84.73
price down icon 2.08%
$28.60
price up icon 1.13%
$98.72
price up icon 2.60%
$145.03
price up icon 0.19%
biotechnology ONC
$337.81
price up icon 1.02%
Capitalizzazione:     |  Volume (24 ore):